All In MedTech

FDA Clearance Tracker · P890064-S032

DIGENE HYBRID CAPTURE 2 (HC2) HPV DNA TESTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 29, 2015 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P890064-S032
Device name
DIGENE HYBRID CAPTURE 2 (HC2) HPV DNA TESTS
Applicant location
Germantown, MD
Received
Apr 28, 2015
Decided
May 29, 2015
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P890064

Device type

Device class
Class III

Every decision under product code MAQ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED IN PENANG, MALAYSIA.

Source documents

Other decisions for Qiagen Gaithersburg, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.